43 related articles for article (PubMed ID: 29198132)
1. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
Zhang SZ; Cai L; Li B
Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
Zhou Y; Ray PS; Zhu J; Stein F; Rettel M; Sekaran T; Sahadevan S; Perez-Perri JI; Roth EK; Myklebost O; Meza-Zepeda LA; von Deimling A; Fu C; Brosig AN; Boye K; Nathrath M; Blattmann C; Lehner B; Hentze MW; Kulozik AE
Nat Commun; 2024 Apr; 15(1):2810. PubMed ID: 38561347
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma.
Chen H; Zhang K; Lu J; Wu G; Yang H; Chen K
Oncotarget; 2017 Dec; 8(68):112623-112635. PubMed ID: 29348851
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
Filippov-Levy N; Cohen-Schussheim H; Tropé CG; Hetland Falkenthal TE; Smith Y; Davidson B; Reich R
Gynecol Oncol; 2018 Mar; 148(3):559-566. PubMed ID: 29310950
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications.
Zhang W; Huang X
Inflamm Regen; 2023 Jun; 43(1):33. PubMed ID: 37391780
[TBL] [Abstract][Full Text] [Related]
6. Abscopal Effect, Extracellular Vesicles and Their Immunotherapeutic Potential in Cancer Treatment.
Salazar A; Chavarria V; Flores I; Ruiz S; Pérez de la Cruz V; Sánchez-García FJ; Pineda B
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175226
[TBL] [Abstract][Full Text] [Related]
7. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
[TBL] [Abstract][Full Text] [Related]
8. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
[TBL] [Abstract][Full Text] [Related]
9. Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy.
Huang X; Wu W; Jing D; Yang L; Guo H; Wang L; Zhang W; Pu F; Shao Z
J Control Release; 2022 Mar; 343():107-117. PubMed ID: 35077741
[TBL] [Abstract][Full Text] [Related]
10. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
Al-Rugeebah A; Alanazi M; Parine NR
Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
[TBL] [Abstract][Full Text] [Related]
11. Engineered exosomes from different sources for cancer-targeted therapy.
Zhang M; Hu S; Liu L; Dang P; Liu Y; Sun Z; Qiao B; Wang C
Signal Transduct Target Ther; 2023 Mar; 8(1):124. PubMed ID: 36922504
[TBL] [Abstract][Full Text] [Related]
12. Current Strategies for Exosome Cargo Loading and Targeting Delivery.
Zeng H; Guo S; Ren X; Wu Z; Liu S; Yao X
Cells; 2023 May; 12(10):. PubMed ID: 37408250
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders.
Kałafut J; Czerwonka A; Czapla K; Przybyszewska-Podstawka A; Hermanowicz JM; Rivero-Müller A; Borkiewicz L
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628760
[TBL] [Abstract][Full Text] [Related]
14. A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers.
Xu J; Wang X; Zhu C; Wang K
Front Cell Dev Biol; 2022; 10():997633. PubMed ID: 36544907
[TBL] [Abstract][Full Text] [Related]
15. Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.
Fatema K; Larson Z; Barrott J
Biocell; 2022 Jun; 46(10):2177-2193. PubMed ID: 35755302
[TBL] [Abstract][Full Text] [Related]
16. The Association of MEG3 lncRNA with Nuclear Speckles in Living Cells.
Hasenson SE; Alkalay E; Atrash MK; Boocholez A; Gershbaum J; Hochberg-Laufer H; Shav-Tal Y
Cells; 2022 Jun; 11(12):. PubMed ID: 35741072
[TBL] [Abstract][Full Text] [Related]
17. Notch-1 promotes the malignant progression of osteosarcoma through the activation of cell division cycle 20.
Gao Y; Bai L; Shang G
Aging (Albany NY); 2020 Dec; 13(2):2668-2680. PubMed ID: 33411691
[TBL] [Abstract][Full Text] [Related]
18. Research progress regarding the role of long non-coding RNAs in osteosarcoma.
Zhang Y; Pu Y; Wang J; Li Z; Wang H
Oncol Lett; 2020 Sep; 20(3):2606-2612. PubMed ID: 32782578
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review).
Sun H; Peng G; Wu H; Liu M; Mao G; Ning X; Yang H; Deng J
Biomed Rep; 2020 Jul; 13(1):15-21. PubMed ID: 32494359
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs in osteosarcoma via various signaling pathways.
Han J; Shen X
J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
